The guide is suitable and can be used for the following audiences:
1. nurses and other trained healthcare workers who can use this manual as a self-study tool and then incorporate its guidance into their practice;
2. governmental and non-governmental employers of lay and professional TB treatment ...adherence workers, who can provide training and guidance to their staff using the guidance in this manual;
3. TB clinicians, programme managers, policy makers and other leaders, to make them aware of the full range of interventions required by a person on TB treatment to complete his or her treatment and thus understand the gap that often exists in the support provided to patients;
4. people who, with enhanced capacity and support, can act as peer counsellors and supporters for people affected by TB. This can include family members who, in most contexts, play an important role in offering support to people with TB.
more
El documento contiene una breve reseña sobre la situación mundial de la tuberculosis; la tuberculosis como problema de salud pública en el país, que incluye el abordaje del análisis de los determinantes y las inequidades sociales y su impacto en el control de la tuberculosis, la evolución y ma...gnitud de la enfermedad, la resistencia a los fármacos antituberculosis y el análisis en poblaciones de riesgo como la coinfección TB_VIH, trabajadores de salud, personas privadas de libertad entre otros.
more
Since 2002, development assistance for health has substantially increased,
especially investments for HIV, tuberculosis (TB) and malaria control. We
undertook a systematic review to assess and synthesize the existing evidence in
the scientific literature on the health impacts of these investments
Version 1.0, 2014-11-21
Introduction:
This document lists TB indicators that can be derived from the recording and reporting tools defined
in Definitions and reporting framework for tuberculosis – 2013 revision (WHO/HTM/TB/2013.2).
Geneva, World Health Organization; 2013. (http://www.who.int/t...b/publications/definitions/en/).
More details on the rationale, calculation and use of these indicators are available in the following
publications:
• Understanding and using tuberculosis data (WHO/HTM/TB/2014.09). Geneva, World Health
Organization. 2014.
(http://www.who.int/tb/publications/understanding_and_using_tb_data/en/)
• Companion handbook to the WHO guidelines for the programmatic management of drugresistant
tuberculosis (WHO/HTM/TB/2014.11). Geneva, World Health Organization. 2014.
(http://www.who.int/tb/publications/pmdt_companionhandbook/en/)
• A guide to monitoring and evaluation for collaborative TB/HIV activities: 2014 revision. Geneva,
World Health Organization. 2014.
more
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
Social protection, a component of the World Health Organization (WHO)’s End TB strategy, has been upheld by Member States as an essential part of the response to tuberculosis in several political declarations, including the 2017 Moscow Declaration to End TB, and both the political declarations of ...both the 2018 and 2023 United Nations General Assembly (UNGA) high-level meetings on the fight against TB. Furthermore, during the 2023 high-level meeting, member states agreed on a new target to ensure that all people with TB have access to a comprehensive package of health and social benefits by 2027.
more
While many of the countries hit by the COVID-19 in the first few months of the year are now beginning to relax lockdown measures as infection and death rates fall, in the regions most affected by HIV, TB and malaria, such as Africa, South Asia and Latin America, the pandemic continues to accelerate.... In lower resource settings, lockdowns are less effective and hard to sustain, and clinical care facilities are extremely limited. In such environments, the response to COVID-19 must focus on containing the pandemic’s spread as far as possible through testing, contact tracing and isolation, protecting the health workforce through training and the provision of personal protective equipment (PPE) and minimizing the knock-on impact on other diseases through shoring up fragile health systems, and adapting existing disease programs.
more
The Compendium of data and evidence-related tools for use in TB planning and programming was developed as a companion document to the People-centred framework for tuberculosis programme planning and prioritization – user guide, published by the World Health Organization (WHO)... in 2019. The compendium is intended to support implementation of the people-centred framework user guide. It can also be used independently to inform decisions taken by national tuberculosis (TB) programmes about the implementation of the tools included in this document.
more
The WHO document "Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance" provides a framework for integrating noncommunicable diseases (NCDs) into existing health programs for HIV/AIDS, tub...erculosis (TB), and sexual and reproductive health (SRH). It emphasizes the importance of a people-centered approach to enhance healthcare accessibility and efficiency, especially in low-resource settings. The document outlines strategies for strengthening policy, financing, capacity building, and health system infrastructure. It offers actionable steps, tools, and case studies to support countries in reducing the burden of NCDs through integrated, holistic care within primary health services.
more
In 2019, the Global Fund’s 6th Replenishment raised more than $USD14 billion to fight HIV, Tuberculosis and Malaria. Just two years later, the world has changed significantly. Put simply: COVID-19 devastated prevention and treatment programs. For the first time since the Global Fund’s founding, ...in 2020 the world lost ground in the fight against HIV, Tuberculosis and Malaria.
The Global Fund moved quickly to support countries to respond to COVID-19 and its impact on the three diseases, repurposing and leveraging additional funding to support urgent needs and adapt programs. Despite those efforts, the need for action to resume progress in the fight against HIV, TB and malaria has never been greater.
The world faces a choice.
more
The WHO Global strategy on human resources for health: workforce 2030 encourages development partners and global health initiatives to leverage their support to health systems in countries to sustainably strengthen the health workforce. To assess the impact of these investments, a methodology was de...veloped and pilot tested by WHO.
The impact assessment tool (consisting of an MS Excel calculator with two subsets) supports users to:
• assess and quantify the health impact of HRH investments made in the context of HIV, tuberculosis (TB) and malaria programmes through their modelled effect on health service coverage of these three diseases; and
• provide aggregate indicative estimates of the range of health workers required to attain high coverage of selected health services.
more
Source: Global Tuberculosis Report 2015
http://www.who.int/tb/publications/global_report/en/
Accessed: 05.10.2019
National Tuberculosis Control Program; Mycobacterial Disease Control National AIDS/STD Program
Las personas infectadas por el virus de la inmunodeficiencia humana (VIH) tienen
29 veces más probabilidades de enfermar de tuberculosis (TB) que las personas
sin VIH que viven en el mismo país. La TB es una de las principales causas de muerte entre las personas infectadas por el VIH: provoca ...la quinta parte de las muertes de personas con VIH en todo el mundo. En 2013, una de cada cuatro muertes por TB en todo el mundo estuvo relacionada con el VIH. Desde 2004, la Organización Mundial de la Salud (OMS) recomienda el conjunto de intervenciones denominadas «actividades de colaboración TB/VIH». Se han realizado avances significativos en la aplicación a nivel mundial de este conjunto de intervenciones, que permitieron salvar aproximadamente 1,3 millones de vidas entre 2005 y 2011.
more
Дане руководcтво призначене для медіцінcкіх працівників іcпользующіх аудіометрію для прийняття обоcнованних рішень, орієнтованих на пацієнта для профілактики і л...кування ототокcічноcті, являющейcя результатом іcпользованія ін'єкційних препаратів другого ряду (ІПВР).
more
В данном документе описываются шаги, необходимые для точного измерения интервала QT (QTc) при мониторинге электрокардиографии (ЭКГ) пациентов, получающих краткосроч...ый режим лечения лекарственно-устойчивого туберкулеза (ЛУ-ТБ) или режим, включающий в схему новые препараты. Кроме того, в данном руководстве представлены требования, которые должны быть учтены при приобретении аппарата ЭКГ для мониторинга безопасности лечения пациентов. В силу того, что каждая модель аппарата имеет особые характеристики расчета QTcF (указанные в описании модели), соответственно, это должно быть учтено при выборе и закупе той или иной модели аппарата.
more
Модуль «Инфекционный контроль» предназначен для (медицинских) работников, которые работают в противотуберкулезных учреждениях и/или с ТБ больными. Цель этого мод...ля: повысить уровень их знаний по общим вопросом инфекционного контроля ТБ. Задачи: после работы с этим модулём участники смогут: – планировать мероприятия для проведения мер инфекционного контроля в конкретном учреждении
– определить степени риска трансмиссии туберкулёза
– описать меры инженерного контроля
– определить нужды для личной защиты
more
В этом документе, основанном на принципах ВОЗ по внедрению аМБП,1 отражены основные виды деятельности и ключевые этапы аМБП для пациентов, получающих лечение ЛУ-ТБ.
Цей документ описує кроки, необхідні для визначення скоригованого інтервалу QT (QTc) в
ході моніторингу ЕКГ пацієнтів, які отримують препарати для лікування ХР ТБ, що... викликають пролонгацію інтервалу QT. Він також надає рекомендації щодо ведення випадків пролонгації QTc.
more
В цьому документі описуються кроки, необхідні для вимірювання скоригованого інтервалу QT (QTc) при моніторингу електрокардіограми (ЕКГ) у пацієнтів, які або перебува...ть на короткостроковій схемі лікування, або використовують нові препарати для лікування туберкульозу з лікарською стійкістю (ХР ТБ). Крім того, наводяться настанови щодо вимог, які слід враховувати при закупівлі апаратів ЕКГ для моніторингу пацієнтів. До тих пір, поки автоматичний розрахунок інтервалу QT з коригуванням Фредеріція (QTcF) (як зазначено в документі) залежить від функціоналу прибору, вибір щодо закупівлі конкретного апарату залишатиметься на розсуд країн.
more